The juvenile macular degeneration market was valued at USD 1.55 Billion in 2024, driven by the growing emphasis on the development of innovative treatment options across the 8 major markets. The market is expected to grow at a CAGR of 7.37% during the forecast period of 2025-2034, with the values likely to reach USD 3.16 Billion by 2034.
Base Year
Historical Year
Forecast Year
The rising advancements in gene therapy and stem cell research are a significant market trend.
The growth in clinical trials assessing new treatments for juvenile macular degeneration is likely to elevate the market value in the forecast period.
The presence of robust regulatory support and the rise in the launch of products to aid people suffering from central vision loss are anticipated to boost market size.
Value in USD Billion
2025-2034
Juvenile Macular Degeneration Market Outlook
*this image is indicative*
Juvenile macular degeneration or juvenile macular dystrophy refers to a group of inherited eye disorders that occur in children and young adults. This eye condition impacts the central vision and, unlike age-related macular degeneration (AMD), impairs vision early in life. Stargardt disease is the most common form of juvenile macular dystrophy and usually results in a vision of 20/200.
The juvenile macular degeneration market is driven by the increasing prevalence of genetic eye disorders and the rising public awareness about the disease. The advancements in genetic testing and imaging technologies are also benefitting the market by augmenting the number of diagnosed cases. The growth in the volume of clinical trials investigating gene therapies and the increased focus on stem cell treatments are anticipated to bolster the market expansion in the forecast period.
Increasing Cases of Juvenile Macular Degeneration to Impact Market Growth
Juvenile macular degeneration (JMD) includes inherited eye disorders such as Stargardt's disease, Best disease, and juvenile retinoschisis, which leads to central vision loss during childhood or young adulthood. In the United States, around 1 in 10,000 children are affected by Stargardt's disease. Further, it is estimated that the disease affects nearly 100,000 individuals in the United States and Europe. The growing awareness of the disease is leading to better diagnosis and management of this inherited eye condition along with prompting the affected individuals to seek treatment. Thus, the increasing cases of genetic eye disorders and the rise in the early detection of juvenile macular degeneration are projected to drive market growth in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type:
Market Breakup by Disease Stage:
Market Breakup by Treatment Type:
Market Breakup by Route of Administration:
Market Breakup by Age Group:
Market Breakup by Disease Type:
Market Breakup by End User:
Market Breakup by Distribution Channel:
Market Breakup by Region:
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
Based on the type of juvenile macular degeneration, the market is segmented into dry age-related juvenile macular degeneration and wet age-related juvenile macular degeneration. Dry age-related juvenile macular degeneration is the more common form of juvenile macular degeneration, characterized by the accumulation of drusen (small yellow deposits) beneath the retina and slower progression than the wet form. On the other hand, wet age-related juvenile macular degeneration occurs due to the growth of abnormal blood vessels beneath the retina and usually leads to rapid vision loss.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States is a major market for juvenile macular degeneration owing to the significant investment in gene therapy and innovative treatments for the treatment of this eye disorder. The presence of key market players and the high healthcare expenditure also favor market expansion. Additionally, heightened awareness about genetic retinal diseases and the rise in government-funded initiatives are poised to impact the market dynamics in the region.
The key features of the market report comprise patent analysis, grants analysis, clinical trial analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Pfizer has a strong focus on the development of biologics and gene therapies for the treatment of retinal diseases. The company is also actively involved in strategic partnerships and acquisitions to boost its gene therapy pipeline.
Bayer AG, a leading pharmaceutical and biomedical company headquartered in Leverkusen, Germany, is a key market player. The company significantly invests in innovative products and research to meet the needs of people impacted by visual impairment.
Roche has a prominent presence in the market, known for its extensive research in developing therapeutics that cause rapid and severe vision loss. The company is engaged in several clinical trials and developing innovative delivery systems for inherited retinal diseases.
Swiss multinational pharmaceutical corporation Novartis AG is one of the leading companies in the market, known for its robust efforts to discover interventions that help in protecting and restoring vision. The company is leveraging a patient-centric approach to develop its diverse portfolio of compounds aimed at patients affected by vision loss.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Panoptica Pharma, Bausch + Lomb, Regeneron Pharmaceuticals Inc., Ocugen Inc., REGENXBIO Inc., and Oxurion NV.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Disease Stage |
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by Age Group |
|
| Breakup by Disease Type |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share